Oral contraceptive use and bone

Current Osteoporosis Reports

Volumn 9, Issue 1, 2011, Pages 6-11

  Wei, Shuying ^a   Winzenberg, Tania ^a   Laslett, Laura L ^a   Venn, Alison ^a   Jones, Graeme ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Adolescent; Bone mass; Bone turnover marker; Fracture; Oral contraceptive; Young adults

Indexed keywords

BIOLOGICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; OSTEOCALCIN; PROGESTERONE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT HEALTH; AGE; ARTICLE; BONE CHARACTERISTICS AND FUNCTIONS; BONE DEMINERALIZATION; BONE DENSITY; BONE MASS; BONE TURNOVER; DOSE CALCULATION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REGIMEN; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FOLLOW UP; FRAGILITY FRACTURE; HORMONAL CONTRACEPTION; HUMAN; LOW DRUG DOSE; OPTIMAL DRUG DOSE; OSTEOLYSIS; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT DURATION; VERTEBRA MALFORMATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BONE DENSITY; CLINICAL TRIALS AS TOPIC; COLLAGEN TYPE I; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; MIDDLE AGED; OSTEOCALCIN; OSTEOPOROSIS; PEPTIDES; TIME FACTORS; YOUNG ADULT;

EID: 79551525394     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-010-0037-9     Document Type: Article

References (25)

1. A Caliri L De Filippis GL Bagnato GF Bagnato 2007 Osteoporotic fractures: mortality and quality of life Panminerva Med 49 21 27 1:STN:280: DC%2BD2s3lvFaluw%3D%3D 17468730
2. BL Riggs S Khosla LJ Melton 3rd 2002 Sex steroids and the construction and conservation of the adult skeleton Endocr Rev 23 279 302 1:CAS:528:DC%2BD38XltlWjtrs%3D 10.1210/er.23.3.279 12050121 (Pubitemid 34651948)
3. MW Greenwald OS Gluck E Lang V Rakov 2005 Oral hormone therapy with 17beta-estradiol and 17beta-estradiol in combination with norethindrone acetate in the prevention of bone loss in early postmenopausal women: dose-dependent effects Menopause 12 741 748 10.1097/01.gme.0000184425.73567.12 16278618 (Pubitemid 41669127)
4. J Heikkinen R Vaheri J Haapalahti U Timonen 2008 A 10-year follow-up of the effect of continuous-combined hormone replacement therapy and its discontinuation on bone in postmenopausal women Menopause Int 14 70 77 10.1258/mi.2008.008008 18519268
5. MH Komulainen H Kroger MT Tuppurainen, et al. 2008 HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial Maturitas 61 85 94 10.1016/j.maturitas.2008.09.012 19434882
6. SL Martins KM Curtis AF Glasier 2006 Combined hormonal contraception and bone health: a systematic review Contraception 73 445 469 1:CAS:528: DC%2BD28Xjs1Wqs7s%3D 10.1016/j.contraception.2006.01.003 16627030
7. Lopez LM, Grimes DA, Schulz KF, Curtis KM: Steroidal contraceptives: effect on bone fractures in women. Cochrane Database Syst Rev 2009, CD006033.
8. • Wei S, Venn A, Jones G: The association between oral contraceptive use, bone mass and fractures in both young and older women. Presented at the ANZBMS 20th ANNUAL SCIENTIFIC MEETING. Adelaide, Australia; September 6-8, 2010. 2010. This study described the associations between OC use, bone mass, and fractures in two population-based samples of both young and older women.
9. Meier C, Brauchli YB, Jick SS, et al.: Use of Depot Medroxyprogesterone Acetate and Fracture Risk. J Clin Endocrinol Metab 2010, 5:4909-4916.
10. M Lattakova M Borovsky J Payer Z Killinger 2009 Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls Eur J Contracept Reprod Health Care 14 207 214 1:CAS:528:DC%2BD1MXnvVyhs7o%3D 10.1080/13625180902838828 19565418 This paper compared the effect of a low-dose OC with an ultra-low-dose OC on bone density and bone turnover in healthy adolescents who had no previous use of hormonal contraceptives and were randomized to different OC formulations
11. ME Beksinska I Kleinschmidt JA Smit TM Farley 2009 Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate Contraception 79 345 349 1:CAS:528:DC%2BD1MXktFahtLc%3D 10.1016/j.contraception.2008.11.009 19341845 This is one of the few prospective studies to examine the effect of low-dose OC on BMD in adolescents who had no previous use of hormonal contraceptive
12. D Scholes L Ichikawa AZ LaCroix, et al. 2010 Oral contraceptive use and bone density in adolescent and young adult women Contraception 81 35 40 1:CAS:528:DC%2BD1MXhsFGrsr%2FM 10.1016/j.contraception.2009.07.001 20004271 This study investigated the association between duration of OC use and BMD in both adolescents and young adults, and also examined different dosages of OC in a population-based sample
13. BL Holmes IA Ludwa KL Gammage, et al. 2010 Relative importance of body composition, osteoporosis-related behaviors, and parental income on bone speed of sound in adolescent females Osteoporos Int 21 1953 1957 1:STN:280: DC%2BC3cflsVGgsg%3D%3D 10.1007/s00198-009-1152-2 20094705
14. • Wei S, Jones G, Thomson R, et al.: Oral contraceptive use and bone mass in women aged 26-36 years. Osteoporos Int 2011, in press. This study investigated the association between OC use and bone mass in a large population-based young adult sample with careful adjustment for confounders.
15. R Chan J Woo W Lau, et al. 2009 Effects of lifestyle and diet on bone health in young adult Chinese women living in Hong Kong and Beijing Food Nutr Bull 30 370 378 20496627
16. ME Beksinska I Kleinschmidt JA Smit, et al. 2009 Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception Contraception 80 128 132 1:CAS:528:DC%2BD1MXovF2rtbk%3D 10.1016/j.contraception.2009.02.001 19631787
17. Allali F, El Mansouri L, Abourazzak F, et al.: The effect of past use of oral contraceptive on bone mineral density, bone biochemical markers and muscle strength in healthy pre and post menopausal women. BMC Womens Health 2009, 9:31.
18. J Sarfati MC de Vernejoul 2009 Impact of combined and progestogen-only contraceptives on bone mineral density Joint Bone Spine 76 134 138 10.1016/j.jbspin.2008.09.014 19181558
19. E Pikkarainen M Lehtonen-Veromaa T Mottonen, et al. 2008 Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study Contraception 78 226 231 1:CAS:528:DC%2BD1cXps12ht7Y%3D 10.1016/j.contraception.2008.05.002 18692613
20. M Hartard C Kleinmond M Wiseman, et al. 2007 Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women Bone 40 444 450 1:CAS:528:DC%2BD2sXmtVGjsQ%3D%3D 10.1016/j.bone.2006.08. 001 16965947 (Pubitemid 46075201)
21. M Palep-Singh A Prentice 2007 Epidemiology of abnormal uterine bleeding Best Pract Res Clin Obstet Gynaecol 21 887 890 10.1016/j.bpobgyn.2007.03.012 17936074 (Pubitemid 350177601)
22. H Agostino G Di Meglio 2010 Low-dose Oral Contraceptives in Adolescents: How Low Can You Go? J Pediatr Adolesc Gynecol 23 195 201 1:STN:280: DC%2BC3cnmsVersQ%3D%3D 10.1016/j.jpag.2009.11.001 20227307
23. MJ Seibel 2006 Biochemical markers of bone turnover part II: clinical applications in the management of osteoporosis Clin Biochem Rev 27 123 138 17268581
24. PD Delmas R Eastell P Garnero, et al. 2000 The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation Osteoporos Int 11 Suppl 6 S2 17 10.1007/s001980070002 11193237 (Pubitemid 32039509)
25. M Herrmann MJ Seibel 2010 The effects of hormonal contraceptives on bone turnover markers and bone health Clin Endocrinol (Oxf) 72 571 583 1:CAS:528:DC%2BC3cXlvVKht78%3D 10.1111/j.1365-2265.2009.03688.x